Keywords: merck/s-p, vytorin, lowers, cholesterol, lipitor, drug, majors

Merck/S-P's Vytorin lowers cholesterol more than Lipitor

Article | 13 June 2006

Print This

US drug majors Merck & Co and Schering-Plough presented strong results from a new clinical study conducted in 1,229 patients with type 2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in